The pathogenesis of osteonecrosis is associated with the side effects of your antiangiogenic mechanisms of such remedies, leading to a disrupted blood flow. Our critique aims to examine recent insights into osteonecrosis activated by new anti-cancer drugs. Most reports focus on the osteonecrosis with the jaw (ONJ); having said that, we discovered t